Fol. Biol. 2010, 56, 242-251
https://doi.org/10.14712/fb2010056060242
Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study
Crossref Cited-by Linking
- Lorincz Balazs, Jury Elizabeth C., Vrablik Michal, Ramanathan Murali, Uher Tomas: The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity. Autoimmunity Reviews 2022, 21, 103088. <https://doi.org/10.1016/j.autrev.2022.103088>
- Naseri Amirreza, Baghernezhad Kosar, Seyedi-Sahebari Sepideh, Alhoseini Seyed Ardalan, Gholipour-khalili Elnaz, Zafarani Fatemeh, Talebi Mahnaz: The association of apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis. Multiple Sclerosis and Related Disorders 2022, 65, 104011. <https://doi.org/10.1016/j.msard.2022.104011>
- Graetz Christiane, Gröger Adriane, Luessi Felix, Salmen Anke, Zöller Daniela, Schultz Janine, Siller Nelly, Fleischer Vinzenz, Bellenberg Barbara, Berthele Achim, Biberacher Viola, Havla Joachim, Hecker Michael, Hohlfeld Reinhard, Infante-Duarte Carmen, Kirschke Jan S, Kümpfel Tania, Linker Ralf, Paul Friedemann, Pfeuffer Steffen, Sämann Philipp, Toenges Gerrit, Weber Frank, Zettl Uwe K, Jahn-Eimermacher Antje, Antony Gisela, Groppa Sergiu, Wiendl Heinz, Hemmer Bernhard, Mühlau Mark, Lukas Carsten, Gold Ralf, Lill Christina M, Zipp Frauke: Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Mult Scler 2019, 25, 661. <https://doi.org/10.1177/1352458518763541>